nsv6309688
- Organism: Homo sapiens
- Study:nstd102 (Clinical Structural Variants)
- Variant Type:copy number variation
- Method Type:Multiple
- Submitted on:GRCh37
- Variant Calls:1
- Validation:Not tested
- Clinical Assertions: Yes
- Region Size:45,638
- Description:NC_000014.8:g.(?_105167703)_(105213340_?)dup AND multiple conditions
- Genome View
- Variant Region Details and Evidence
- Validation Information
- Clinical Assertions
- Genotype Information
Genome View
Select assembly:Overlapping variant regions from other studies: 330 SVs from 55 studies. See in: genome view
Overlapping variant regions from other studies: 330 SVs from 55 studies. See in: genome view
Variant Region Placement Information
Variant Region ID | Placement Type | Score | Assembly | Assembly Unit | Reciprocity | Sequence ID | Chr | Inner Start | Inner Stop |
---|---|---|---|---|---|---|---|---|---|
nsv6309688 | Remapped | Perfect | GRCh38.p12 | Primary Assembly | First Pass | NC_000014.9 | Chr14 | 104,701,366 | 104,747,003 |
nsv6309688 | Submitted genomic | GRCh37 (hg19) | Primary Assembly | NC_000014.8 | Chr14 | 105,167,703 | 105,213,340 |
Variant Call Information
Variant Call ID | Type | Method | Analysis | Subject Phenotype | Clinical Interpretation | Source of Interpretation | ClinVar ID |
---|---|---|---|---|---|---|---|
nssv17973383 | duplication | Multiple | Multiple | Autosomal dominant intermediate Charcot-Marie-Tooth disease type E; CHARCOT-MARIE-TOOTH DISEASE, DOMINANT INTERMEDIATE E; CMTDIE; Charcot-Marie-Tooth disease dominant intermediate E; FOCAL SEGMENTAL GLOMERULOSCLEROSIS 5; FSGS5; Focal segmental glomerulosclerosis 5; Genetic steroid-resistant nephrotic syndrome | Uncertain significance | ClinVar | RCV002014693.1, VCV001450164.1 |
Variant Call Placement Information
Variant Call ID | Placement Type | Score | HGVS | Assembly | Reciprocity | Sequence ID | Chr | Inner Start | Inner Stop |
---|---|---|---|---|---|---|---|---|---|
nssv17973383 | Remapped | Perfect | NC_000014.9:g.(?_1 04701366)_(1047470 03_?)dup | GRCh38.p12 | First Pass | NC_000014.9 | Chr14 | 104,701,366 | 104,747,003 |
nssv17973383 | Submitted genomic | NC_000014.8:g.(?_1 05167703)_(1052133 40_?)dup | GRCh37 (hg19) | NC_000014.8 | Chr14 | 105,167,703 | 105,213,340 |
No validation data were submitted for this variant
Clinical Assertions
Variant Call ID | HGVS | Type | Allele Origin | Subject Phenotype | Clinical Interpretation | Source of Interpretation | ClinVar ID |
---|---|---|---|---|---|---|---|
nssv17973383 | GRCh37: NC_000014.8:g.(?_105167703)_(105213340_?)dup | duplication | germline | Autosomal dominant intermediate Charcot-Marie-Tooth disease type E; CHARCOT-MARIE-TOOTH DISEASE, DOMINANT INTERMEDIATE E; CMTDIE; Charcot-Marie-Tooth disease dominant intermediate E; FOCAL SEGMENTAL GLOMERULOSCLEROSIS 5; FSGS5; Focal segmental glomerulosclerosis 5; Genetic steroid-resistant nephrotic syndrome | Uncertain significance | ClinVar | RCV002014693.1, VCV001450164.1 |